Stable suppository formulations effecting bioavailability of .DE

Details Stable suppository formulations effecting bioavailability of .DE Stable suppository formulations effecting bioavailability of .DE

1993-05-21

1995-02-14

Phelan, Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424DIG15, 514966, A61F 902

Patent

active

053893751

ABSTRACT:
Suppository formulations having long-term stability and containing readily bioavailable .DELTA..sup.9 -THC derivatives.

REFERENCES:
patent: 4933363 (1990-06-01), ElSolhy
ElSohy et al., Rectal Bioavailability of delta-9-tetrahydrocannabinol from various esters, Pharm Col. Biochem Behav., 40:497-502, 1991.
ElSohy et al., Rectal bioavailable of .DELTA..sup.9 -tetrahydrocannabinol from the succinate ester in monkeys, Je Pharm. Sci., 80(10): 942-945, 1991.

Affiliated with

Also associated with

Rating

Stable suppository formulations effecting bioavailability of .DE does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable suppository formulations effecting bioavailability of .DE, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable suppository formulations effecting bioavailability of .DE will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-286031